ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3) - INVIMA Registration 49e609314bf9c4a7b86b0299e7f13042
Access comprehensive regulatory information for ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3) (ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 49e609314bf9c4a7b86b0299e7f13042 and manufactured by SIEMENS HEALTHCARE S.A.S.. The device was registered on February 13, 2033.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
EL ENSAYO ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3) ES PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE ANTIESTREPTOLISINA-0 EN SUERO Y PLASMA HUMANOS (HEPARINA DE LITIO, EDTA, HEPARINA DE SODIO) CON EL ATELLICA CH ANALYZER.
THE ATELLICA CH ANTI-STREPTOLYSIN-O_3 (ASO_3) ASSAY IS FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF ANTISTREPTOLYSIN-0 IN HUMAN SERUM AND PLASMA (LITHIUM HEPARIN, EDTA, SODIUM HEPARIN) WITH THE ATELLICA CH ANALYZER.